834 related articles for article (PubMed ID: 16472587)
21. Germline MLH1 Mutations Are Frequently Identified in Lynch Syndrome Patients With Colorectal and Endometrial Carcinoma Demonstrating Isolated Loss of PMS2 Immunohistochemical Expression.
Dudley B; Brand RE; Thull D; Bahary N; Nikiforova MN; Pai RK
Am J Surg Pathol; 2015 Aug; 39(8):1114-20. PubMed ID: 25871621
[TBL] [Abstract][Full Text] [Related]
22. Mutations associated with HNPCC predisposition -- Update of ICG-HNPCC/INSiGHT mutation database.
Peltomäki P; Vasen H
Dis Markers; 2004; 20(4-5):269-76. PubMed ID: 15528792
[TBL] [Abstract][Full Text] [Related]
23. Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional features.
Belvederesi L; Bianchi F; Loretelli C; Gagliardini D; Galizia E; Bracci R; Rosati S; Bearzi I; Viel A; Cellerino R; Porfiri E
Eur J Hum Genet; 2006 Jul; 14(7):853-9. PubMed ID: 16724012
[TBL] [Abstract][Full Text] [Related]
24. Polymorphisms and HNPCC: PMS2-MLH1 protein interactions diminished by single nucleotide polymorphisms.
Yuan ZQ; Gottlieb B; Beitel LK; Wong N; Gordon PH; Wang Q; Puisieux A; Foulkes WD; Trifiro M
Hum Mutat; 2002 Feb; 19(2):108-13. PubMed ID: 11793469
[TBL] [Abstract][Full Text] [Related]
25. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.
Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK
J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016
[TBL] [Abstract][Full Text] [Related]
26. Constitutional Mismatch Repair Deficiency in Israel: High Proportion of Founder Mutations in MMR Genes and Consanguinity.
Baris HN; Barnes-Kedar I; Toledano H; Halpern M; Hershkovitz D; Lossos A; Lerer I; Peretz T; Kariv R; Cohen S; Half EE; Magal N; Drasinover V; Wimmer K; Goldberg Y; Bercovich D; Levi Z
Pediatr Blood Cancer; 2016 Mar; 63(3):418-27. PubMed ID: 26544533
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel.
Shia J; Tang LH; Vakiani E; Guillem JG; Stadler ZK; Soslow RA; Katabi N; Weiser MR; Paty PB; Temple LK; Nash GM; Wong WD; Offit K; Klimstra DS
Am J Surg Pathol; 2009 Nov; 33(11):1639-45. PubMed ID: 19701074
[TBL] [Abstract][Full Text] [Related]
28. Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations.
Wu Y; Berends MJ; Mensink RG; Kempinga C; Sijmons RH; van Der Zee AG; Hollema H; Kleibeuker JH; Buys CH; Hofstra RM
Am J Hum Genet; 1999 Nov; 65(5):1291-8. PubMed ID: 10521294
[TBL] [Abstract][Full Text] [Related]
29. Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene.
Wagner A; Barrows A; Wijnen JT; van der Klift H; Franken PF; Verkuijlen P; Nakagawa H; Geugien M; Jaghmohan-Changur S; Breukel C; Meijers-Heijboer H; Morreau H; van Puijenbroek M; Burn J; Coronel S; Kinarski Y; Okimoto R; Watson P; Lynch JF; de la Chapelle A; Lynch HT; Fodde R
Am J Hum Genet; 2003 May; 72(5):1088-100. PubMed ID: 12658575
[TBL] [Abstract][Full Text] [Related]
30. Clinical and Molecular Characterization of Brazilian Patients Suspected to Have Lynch Syndrome.
Carneiro da Silva F; Ferreira JR; Torrezan GT; Figueiredo MC; Santos ÉM; Nakagawa WT; Brianese RC; Petrolini de Oliveira L; Begnani MD; Aguiar-Junior S; Rossi BM; Ferreira Fde O; Carraro DM
PLoS One; 2015; 10(10):e0139753. PubMed ID: 26437257
[TBL] [Abstract][Full Text] [Related]
31. Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer.
de Jong AE; van Puijenbroek M; Hendriks Y; Tops C; Wijnen J; Ausems MG; Meijers-Heijboer H; Wagner A; van Os TA; Bröcker-Vriends AH; Vasen HF; Morreau H
Clin Cancer Res; 2004 Feb; 10(3):972-80. PubMed ID: 14871975
[TBL] [Abstract][Full Text] [Related]
32. Familial mutations in PMS2 can cause autosomal dominant hereditary nonpolyposis colorectal cancer.
Worthley DL; Walsh MD; Barker M; Ruszkiewicz A; Bennett G; Phillips K; Suthers G
Gastroenterology; 2005 May; 128(5):1431-6. PubMed ID: 15887124
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases.
Mueller J; Gazzoli I; Bandipalliam P; Garber JE; Syngal S; Kolodner RD
Cancer Res; 2009 Sep; 69(17):7053-61. PubMed ID: 19690142
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
[TBL] [Abstract][Full Text] [Related]
35. Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation.
Nakagawa H; Lockman JC; Frankel WL; Hampel H; Steenblock K; Burgart LJ; Thibodeau SN; de la Chapelle A
Cancer Res; 2004 Jul; 64(14):4721-7. PubMed ID: 15256438
[TBL] [Abstract][Full Text] [Related]
36. The frequency of previously undetectable deletions involving 3' Exons of the PMS2 gene.
Vaughn CP; Baker CL; Samowitz WS; Swensen JJ
Genes Chromosomes Cancer; 2013 Jan; 52(1):107-12. PubMed ID: 23012243
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms underlying mismatch repair deficiencies in normal cells.
Moliaka YK; Cella M; Chudina AP; Kolesnikova TN; Terracciano L; Cathomas G; Bochkov NP; Buerstedde JM
Genes Chromosomes Cancer; 1997 Nov; 20(3):305-9. PubMed ID: 9365839
[TBL] [Abstract][Full Text] [Related]
38. Analysis of mismatch repair defects in the familial occurrence of lymphoma and colorectal cancer.
Teruya-Feldstein J; Greene J; Cohen L; Popplewell L; Ellis NA; Offit K
Leuk Lymphoma; 2002 Aug; 43(8):1619-26. PubMed ID: 12400605
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of germline mutations of MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer families from Spain.
Caldes T; Godino J; de la Hoya M; Garcia Carbonero I; Perez Segura P; Eng C; Benito M; Diaz-Rubio E
Int J Cancer; 2002 Apr; 98(5):774-9. PubMed ID: 11920650
[TBL] [Abstract][Full Text] [Related]
40. MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer.
Charbonnier F; Olschwang S; Wang Q; Boisson C; Martin C; Buisine MP; Puisieux A; Frebourg T
Cancer Res; 2002 Feb; 62(3):848-53. PubMed ID: 11830542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]